ArticlePloS one2025
Traffic flow prediction based on spatiotemporal encoder-decoder model.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- STAC-Net: A hierarchical framework for modeling and predicting urban traffic flow with uncertainty quantification.PloS one · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To more effectively capture the periodic and dynamic changes in urban traffic flow and the spatiotemporal correlation of complex road networks, a new traffic flow prediction method, the Enhanced Spatiotemporal Graph Convolutional Network Encoder-Decoder Model (ESGCN-EDM), is proposed. The model achieves a significant enhancement in prediction accuracy through the introduction of the attention-based Personalized-enhanced Fusion Graph Convolutional Network (aPFGCN) and the Temporal Convolutional Bidirectional Long Short-Term Memory (TCBiL) module. The aPFGCN module effectively reduces the dimensionality of features and decreases model complexity to obtain the final node feature representation by personalizing the adjustment of node influence coefficients and applying Fourier transform and inverse transform techniques. Additionally, by incorporating an attention mechanism, it enhances the model's ability to focus on important information and effectively captures the spatial topological relationships within the traffic network. The TCBiL module integrates 1D convolution with BiLSTM to form a unified temporal feature extraction module. The 1D convolution is utilized to extract local features from the time series, while the BiLSTM captures long-term dependencies within the time series. This allows for simultaneous feature extraction and temporal modeling, thereby enhancing the model's efficiency and performance, and strengthening its ability to model time series. In the encoder part of the ESGCN-EDM, the aPFGCN is combined with the TCBiL to handle the spatiotemporal coupling interactions of the road network. The decoder part then performs multi-step predictions based on spatiotemporal sequences using the TCBiL and CNN, generating high-dimensional representations. Extensive experiments conducted on two real-world road traffic datasets demonstrate that the ESGCN-EDM model consistently outperforms other benchmark models in 1-hour, 30-minute, and 15-minute traffic flow predictions. Specifically, on the PeMSD8 dataset, the model achieves reductions in MAE, RMSE, and SMAPE by 7.9%, 2.1%, and 16.9%, respectively, compared to the AMRGCN model for 1-hour predictions. Similarly, on the PeMSD4 dataset, the model reduces MAE, RMSE, and MAPE by 1.8%, 1.1%, and 3.0%, respectively. These results validate the efficacy of the proposed model and its ability to significantly enhance the accuracy of traffic flow forecasting.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.